Zhicheng Yang Selected Research

NADPH Oxidase 4

1/2019	Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
1/2017	Nrf2 mediates redox adaptation in NOX4-overexpressed non-small cell lung cancer cells.
12/2016	NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
6/2014	NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhicheng Yang Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 01/2011
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2015
5	Rheumatoid Arthritis 04/2022 - 12/2019
5	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2014
2	Ankylosing Spondylitis 01/2020 - 01/2020
2	Diabetic Nephropathies (Diabetic Nephropathy) 12/2016 - 12/2013
2	Inflammation (Inflammations) 12/2016 - 01/2015
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Tachycardia (Tachyarrhythmias) 04/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Osteoarthritis 10/2020
1	Fatigue 05/2019
1	Pathologic Processes 01/2019
1	Mouth Neoplasms (Oral Cancer) 02/2018
1	Breast Neoplasms (Breast Cancer) 07/2017
1	Hypertrophy 12/2016
1	Albuminuria 12/2016
1	Body Weight (Weight, Body) 12/2016
1	Fibrosis (Cirrhosis) 12/2016
1	Hyperglycemia 12/2016
1	Glioma (Gliomas) 10/2015
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2011

Drug/Important Bio-Agent (IBA)

4	NADPH Oxidase 4IBA 01/2019 - 06/2014
2	Long Noncoding RNAIBA 01/2022 - 07/2017
2	Vascular Endothelial Growth Factor CIBA 01/2020 - 01/2018
2	setanaxibIBA 01/2019 - 12/2016
2	EnzymesIBA 07/2018 - 10/2015
2	Biological ProductsIBA 10/2015 - 01/2015
1	Toll-Like Receptor 4IBA 04/2022
1	MucinsIBA 01/2021
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 10/2020
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2019
1	AlloysIBA 05/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	diosmetinIBA 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2018
1	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2018
1	Pharmaceutical PreparationsIBA 02/2018
1	Oxygen (Dioxygen)IBA 02/2018
1	Niclosamide FDA Link 02/2018
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	Blood Glucose (Blood Sugar)IBA 12/2016
1	CreatinineIBA 12/2016
1	andrographolideIBA 12/2016
1	NitrogenIBA 12/2016
1	Triglycerides (Triacylglycerol)IBA 12/2016
1	Urea (Carbamide)FDA LinkGeneric 12/2016
1	Glucose (Dextrose)FDA LinkGeneric 12/2016
1	Glutamine (L-Glutamine)FDA Link 12/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	CytokinesIBA 01/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Fibronectins (Fibronectin)IBA 12/2013
1	Emodin (Archin)IBA 12/2013
1	BerberineIBA 01/2011

Therapy/Procedure

3	Therapeutics 02/2018 - 01/2011
2	Drug Therapy (Chemotherapy) 01/2015 - 01/2011
1	Critical Care (Surgical Intensive Care) 04/2021
1	Chemoradiotherapy 01/2015
1	Radiotherapy 01/2015